Status:
UNKNOWN
Pentastarch Use in Cardiac Surgery
Lead Sponsor:
Hamilton Health Sciences Corporation
Conditions:
Cardiac Surgery
Cardiopulmonary Bypass
Eligibility:
All Genders
Phase:
NA
Brief Summary
Patients undergoing cardiac surgery with cardiopulmonary bypass require significant fluid administration. Fluids are used routinely to replace blood lost during and after surgery. Significant amounts ...
Eligibility Criteria
Inclusion
- All patients undergoing either coronary artery bypass surgery or valve surgery requiring the use of cardiopulmonary bypass circuit
Exclusion
- Emergency surgery
- Regurgitant valve pathology
- Redo surgery
- Significant left ventricular (LV) dysfunction
- Significant renal insufficiency
- Anticipation of associated procedure - eg carotid endarterectomy
- Ongoing sepsis or endocarditis
- Received aspirin (ASA) or Plavix within 96 hours of surgery
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00182377
Last Update
September 20 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hamilton Health Sciences - General Division
Hamilton, Ontario, Canada, lL8L 2X2